Precision medicine strategies and successes in improving patient outcomes are key themes when hospital and health network CEOs and administrators gather in Nashville Sept. 12–13 to hear from innovators at Vanderbilt University Medical Center, Geisinger Health, Northwell Health, Moffitt Cancer Center, and Seattle Children’s Hospital, among others.
“Precision Medicine for Hospital CEOs: What You Need to Know about Genetic Testing, Precision Medicine, and Population Health Management” (https://www.precisionmedicineforhospitals.com) will feature first-mover and early-adopter health networks sharing the strategies of their precision medicine programs and the patient care successes and outcomes.
Keynote speaker is Jeffery Balser, MD, PhD, CEO of Vanderbilt University Medical Center, which is internationally recognized for its pioneering efforts to bring precision medicine into daily clinical care. Attendees will gain insight into the early successes of precision medicine at Vanderbilt and learn how the health care big data base at Vanderbilt is being used to inform population health initiatives while also guiding the care clinicians provide daily.
Among the 20 speakers sharing their experiences at bringing precision medicine, genetic medicine, and genetic testing into the daily care provided to their patients will be:
- Mark Van Oene, senior vice president and chief commercial officer, Illumina: Envisioning the Future of Genomics in Clinical Care and Genetic Testing and Gene Sequencing’s Role in Precision Medicine.
- Huntington F. Willard, PhD, director, Geisinger National Precision Health: A Clinical Imperative: Genomics, Population Health, and Precision Medicine at Geisinger Health.
- Howard L. McLeod, PharmD, medical director, Personalized Medicine Institute, Moffitt Cancer Center: Precision Medicine in Oncology/Cancer Care.
- Julie A Johnson, PharmD, dean, College of Pharmacy, University of Florida: Precision Medicine in Pharmacogenomics.
- Josh Denny, MD, vice president of personalized medicine, Vanderbilt University Medical Center: Genetic and Molecular Data in Population Health.
Two sessions of particular interest involve how health care organizations are using precision medicine with providers in arrangements that are delivering substantial reimbursement in shared savings arrangements with major health plans. They are:
- Philip Chen, MD, PhD, chief healthcare informatics officer, Sonic Healthcare USA: Case Study of Precision Medicine Shared Saving Initiative: Use of Healthcare Big Data, Lab Results, and Analytics to Support Office-Based Physicians in Managing Patients with Diabetes and Chronic Diseases.
- Richard VanNess, MS, product manager, TriCore Reference Laboratories: Partnering with Payers: How Our Health Network Helps to Achieve Better Patient Outcome at Less Cost in Shared Savings Arrangements.
For more information and to register, go to https://www.precisionmedicineforhospitals.com (or copy and paste this URL in your browser: https://www.precisionmedicineforhospitals.com). Or contact Chris Garcia at 512-264-7103.